BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9932947)

  • 1. Alpha1-antichymotrypsin gene polymorphism and susceptibility to Parkinson's disease.
    Muñoz E; Obach V; Oliva R; Martí MJ; Ezquerra M; Pastor P; Ballesta F; Tolosa E
    Neurology; 1999 Jan; 52(2):297-301. PubMed ID: 9932947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The homozygote AA genotype of the alpha1-antichymotrypsin gene may confer protection against early-onset Parkinson's disease in women.
    Lin JJ; Yueh KC; Chang CY; Chen CH; Lin SZ
    Parkinsonism Relat Disord; 2004 Dec; 10(8):469-73. PubMed ID: 15542006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic association between susceptibility to Parkinson's disease and alpha1-antichymotrypsin polymorphism.
    Yamamoto M; Kondo I; Ogawa N; Asanuma M; Yamashita Y; Mizuno Y
    Brain Res; 1997 Jun; 759(1):153-5. PubMed ID: 9219874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alpha1-antichymotrypsin A-allele in German Parkinson disease patients.
    Grasbon-Frodl EM; Egensperger R; Kösel S; Krüger R; Riess O; Mehraein P; Graeber MB
    J Neural Transm (Vienna); 1999; 106(7-8):729-36. PubMed ID: 10907731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic association analysis of alpha-1-antichymotrypsin polymorphism in Parkinson's disease.
    Wang YC; Liu HC; Liu TY; Hong CJ; Tsai SJ
    Eur Neurol; 2001; 45(4):254-6. PubMed ID: 11385264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between polymorphism of alpha 1-antichymotrypsin and apolipoprotein E gene and Parkinson's disease in Shanghai Hans].
    Hao Y; Xie H; Xu L
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1172-5. PubMed ID: 11769703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease.
    Tang G; Xie H; Xu L; Hao Y; Lin D; Ren D
    Am J Med Genet; 2002 May; 114(4):446-9. PubMed ID: 11992569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACT and UCH-L1 polymorphisms in Parkinson's disease and age of onset.
    Wang J; Zhao CY; Si YM; Liu ZL; Chen B; Yu L
    Mov Disord; 2002 Jul; 17(4):767-71. PubMed ID: 12210873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-1-antichymotrypsin gene polymorphism and susceptibility to multiple system atrophy (MSA).
    Furiya Y; Hirano M; Kurumatani N; Nakamuro T; Matsumura R; Futamura N; Ueno S
    Brain Res Mol Brain Res; 2005 Aug; 138(2):178-81. PubMed ID: 15907346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases.
    Egensperger R; Kösel S; Schnopp NM; Mehraein P; Graeber MB
    Neuropathol Appl Neurobiol; 1997 Aug; 23(4):315-21. PubMed ID: 9292870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.
    Kamboh MI; Sanghera DK; Ferrell RE; DeKosky ST
    Nat Genet; 1995 Aug; 10(4):486-8. PubMed ID: 7670501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-1-antichymotrypsin gene polymorphism and risk for sporadic Alzheimer's disease in a German population.
    Schwab SG; Bagli M; Papassotiropoulos A; Jessen F; Maier W; Rao ML; Heun R
    Dement Geriatr Cogn Disord; 1999; 10(6):469-72. PubMed ID: 10559561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease.
    Kamboh MI; Minster RL; Kenney M; Ozturk A; Desai PP; Kammerer CM; DeKosky ST
    Neurobiol Aging; 2006 Oct; 27(10):1435-9. PubMed ID: 16137793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of alpha1-antichymotrypsin polymorphism with cerebral amyloid angiopathy.
    Yamada M; Sodeyama N; Itoh Y; Suematsu N; Otomo E; Matsushita M; Mizusawa H
    Ann Neurol; 1998 Jul; 44(1):129-31. PubMed ID: 9667601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATXN8 -62 G/A promoter polymorphism and risk of Taiwanese Parkinson's disease.
    Chen IC; Wu YR; Yang SJ; Kao SH; Chen YC; Chang KH; Lee CM; Lee-Chen GJ; Chen CM
    Eur J Neurol; 2012 Nov; 19(11):1462-9. PubMed ID: 22577844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E and alpha1-antichymotrypsin genotypes and age of onset of familial Alzheimer's disease.
    Axelman K; Basun H; Lannfelt L
    Dement Geriatr Cogn Disord; 1999; 10(1):1-5. PubMed ID: 9844031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between alpha1-antichymotrypsin polymorphism and late-onset depressive disorder.
    Ohara K; Suzuki Y; Yoshida K; Terada H; Ohara K
    Psychiatry Res; 1999 Nov; 88(3):221-6. PubMed ID: 10622342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5,10-methylenetetrahydrofolate reductase C677T gene polymorphism can influence age at onset of Parkinson's disease.
    Lin JJ; Yueh KC; Liu CS; Liu JT; Lin SZ
    Acta Neurol Taiwan; 2007 Sep; 16(3):150-7. PubMed ID: 17966954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson's disease patients.
    Bialecka M; Klodowska-Duda G; Kurzawski M; Slawek J; Gorzkowska A; Opala G; Bialecki P; Sagan L; Droździk M
    Parkinsonism Relat Disord; 2008 Dec; 14(8):636-40. PubMed ID: 18362084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The alpha-synuclein gene microsatellite polymorphism and late-onset sporadic Parkinson's disease susceptibility].
    Zhao XP; Zheng HM; Xie HJ; Ding SJ; Ren DM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):339-41. PubMed ID: 15300629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.